SHL Telemedicine completes acquisition of GPH Cordiva

TEL AVIV, Israel and ZURICH, April 1, 2015 /PRNewswire/ -- SHL Telemedicine Ltd. (SIX Swiss Exchange: SHLTN), a leading provider and developer of advanced personal telemedicine solutions, today announced that it has completed the acquisition of GPH (Gesellschaft fur Patientenhilfe), based in Munich, for a cash purchase price of € 7.6 million. GPH's nationwide German telemedicine programme Cordiva currently cares for about 10,000 chronic heart failure patients in daily regular care. GPH, a subsidiary of US-based Alere Inc., has AOK Bayern and AOK North East amongst its major clients.

About SHL Telemedicine 
SHL Telemedicine is engaged in developing and marketing personal telemedicine systems and the provision of medical call center services, with a focus on cardiovascular and related diseases, to end users and to the healthcare community. SHL Telemedicine offers its services and personal telemedicine devices to subscribers utilizing telephonic and Internet communication technology. The Company operates in Israel, Germany, India and the United States in one business segment, Telemedicine services. SHL is listed on the SIX Swiss Exchange (SHLTN, ISIN: IL0010855885, Security No.: 1128957) and has an ADR program listed over-the counter; Symbol: SMDCY. For more information, please visit our web site at www.shl-telemedicine.com.

Some of the information contained in this press release contains forward-looking statements. Readers are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those in the forward-looking statements as a result of various factors. SHL Telemedicine undertakes no obligation to publicly update or revise any forward-looking statements.

SOURCE SHL Telemedicine Ltd.

Related Links

http://www.shl-telemedicine.com

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED